Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory Bailey currently holds 2,020,071 shares of Opexa Therapeutics, Inc. (OPXA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Bailey has been a net seller of OPXA stock. They have purchased $18.6M and sold $62.1M worth of shares.
Gregory Bailey's most recent insider trade was on Nov 13, 2025, when they purchased 400,000 shares at $7.50 per share.
Gregory Bailey serves as Executive at Opexa Therapeutics, Inc. (OPXA). They have executed 135 insider transactions totaling $80.7M over their tenure at the company.
Gregory Bailey holds the position of Executive at Opexa Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Gregory Bailey has shown a selling trading pattern, with $18.6M in total purchases and $62.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory Bailey was on Oct 3, 2022, when they sold $383.7M worth of BHVN shares. This transaction involved 2,583,658 shares at $148.50 per share.
Gregory Bailey currently owns 2,020,071 shares of Opexa Therapeutics, Inc. (OPXA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory Bailey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory Bailey has 135 Form 4 filings on record as an insider at Opexa Therapeutics, Inc..
Set alerts for Gregory Bailey and 40,000+ other insiders.